33 results
Thumbnail

000594 - The Role of Asthma and COVID-19 in Shaping the Severity of Pediatric Mycoplasma pneumoniae Infections: A Regional Perspective from the United States

Thumbnail

001503 - Urticaria exacerbations in children with chronic urticaria receiving COVID-19 vaccination

Thumbnail

- D3.100 - Risk Factors and Biomarkers for COVID-19 and Allergic Diseases

Thumbnail

- D3.115 - Outcome and complications of COVID-19 among children with asthma in South Korea: a national incident cohort study

Thumbnail

D3.273 - Assessing Anaphylaxis in COVID-19 vaccines: Application of amended Brighton Collaboration Criteria

Thumbnail

D3.378 - Long Covid in epithelial barrier type2 disease: an Italian experience

Thumbnail

D1.108 - Grape polyphenols increase the concentration of BPI in asthma patients who have had SARS-CoV-2

Thumbnail

D1.276 - Social #anaphylaxis: how social media reveals shifting trends in public health concerns

Thumbnail

D1.423 - Listening to Urticaria Patients Through Social Media: Analyzing the Impact of the COVID-19 Pandemic

Thumbnail

D1.424 - Clinical-epidemiological profile of patients with Post-Covid syndrome followed at a medical school outpatient clinic

Thumbnail

D1.426 - Cellular immunity profile in patients with urolithiasis in the presence of post-Covid syndrome

Thumbnail

100334 - Chryseobacterium indologenes: An emerging bacteria with antiviral properties

Thumbnail

D1.188 - Diet Diversity in Early Childhood, and Prevalence of Food Allergies in Children with Autism Spectrum Disorder

Thumbnail

D1.196 - Characterizing the detectable milk protein allergens in milk ladder foods

Thumbnail

D2.206 - Evaluation of sustained unresponsiveness in children with IgE-Mediated Allergy to Cow's Milk Proteins Trough Oral Tolerance Induction Protocols

Thumbnail

D2.346 - Assessment of the safety of allogenic natural killer cells in the treatment of metastatic colon cancer

Thumbnail

D3.140 - Xiaoqinglong Decoction Combined with Yupingfeng Powder Alleviates Allergic Rhinitis Complicated with Asthma by Inhibiting B Lymphocyte Activation via JAK2/STAT1/MHC-II signaling pathway

Thumbnail

D3.312 - Lymphatic supplementation improves atopic dermatitis in dogs

Thumbnail

D1.253 - Comparison of Immune-Related Adverse Events in Patients Treated with Atezolizumab and Durvalumab: A Critical Concern for Clinical Management

Thumbnail

D2.184 - Trends in aeroallergen immunotherapy prescription